What to know about GLP-1 supplements for weight loss
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking off. But do these products work?
Novo Nordisk slides on pressure from Lilly’s pill study
Novo Nordisk A/S slumped after a pill from rival Eli Lilly & Co. helped patients shed weight and control blood sugar about as well as its injected blockbuster Ozempic. The stock dropped as much as 9.8% to 380 kroner early in Copenhagen, the first trading day since the Thursday announcement that buoyed Lilly. The triumph […]
GLP‐1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting
Abstract Aims Glucagon-like peptide-1 (GLP-1) receptor agonists, alongside dual receptor agonists targeting glucose-dependent insulinotropic polypeptide (GIP) receptors, represent transformative therapies for obesity management. Despite their increasing use, patient perspectives of these treatments remain underexplored. This exploratory study aimed to examine the experiences and attitudes of individuals using GLP-1 medications (GLP-1s) for weight loss, focusing on […]
Diabetes drugs GLP-1RA and SGLT2i lower dementia risk in older adults, study finds
A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of glucose-lowering drugs used in type 2 diabetes, were associated with a significantly reduced risk of Alzheimer’s disease and related dementias (ADRD). These findings suggest potential neuroprotective benefits and highlight drug repurposing as a promising strategy for ADRD prevention.
Can GLP-1 Medications Help Treat Alcohol Use Disorder?
GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy and used to treat coexisting conditions.